Amplia Therapeutics Limited (ASX:ATX; OTCQB:INNMF), (“Amplia” or the “Company”), announces that it is initiating a Phase 2b study of narmafotinib in pancreatic cancer exploring a new dosing regimen.

Kade Reed describes it as “just another game for me”. Despite it being his NRL debut, with the No.7 on his back, in the biggest club game of the year, after replacing the son of the coach who just ...

Initiator proteins direct the assembly of DNA synthesis enzymes at chromosomal sites in a highly regulated manner. In bacteria, the initiator DnaA cooperatively oligomerizes at the site of replication ...

Thirteen critical vulnerabilities have been found in the vm2 JavaScript sandbox package that could allow an attacker’s code ...

Angel Au-Yeung is a finance and technology reporter for The Wall Street Journal in San Francisco. She covers business leaders, startups and Silicon Valley culture. She has won several national awards ...

Thanks for subscribing! Look out for your first newsletter in your inbox soon! The best things in life are free. Sign up for our email to enjoy your city without spending a thing (as well as some ...

Aashika’s near two decades stint in business and finance journalism has led her to report, write, edit and lead teams covering public investing, private investing and personal investing both in India ...

Aashika’s near two decades stint in business and finance journalism has led her to report, write, edit and lead teams covering public investing, private investing and personal investing both in India ...

Thanks for subscribing! Look out for your first newsletter in your inbox soon! The best things in life are free. Sign up for our email to enjoy your city without spending a thing (as well as some ...

James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...

Your subscription provides you with unrivalled insight into the most significant national and global issues with full access to The Australian on your desktop, tablet and mobile. You can choose from a ...